AIC
JAZZ icon

Aurora Investment Counsel’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aurora Investment Counsel’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,175
Closed -$320K – 111
2014
Q2 		$320K Sell
2,175
-98
-4% -$13.6K 0.2% 98
2014
Q1 		$315K Sell
2,273
-16,745
-88% -$2.52M 0.2% 99
2013
Q4 		$2.41M Sell
19,018
-8,112
-30% -$839K 1.59% 4
2013
Q3 		$2.5M Buy
27,130
+138
+0.5% +$11.1K 1.82% 2
2013
Q2 		$1.95M Buy
+26,992
New +$1.65M 1.52% 10

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Aurora Investment Counsel's JAZZ Position: Q3 2014 in Review

Aurora Investment Counsel sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2014, closing a stake of 2,175 shares — an estimated $320K sold.

Aurora Investment Counsel first reported a position in JAZZ in Q2 2013 and held it in 5 quarters. The position peaked at $2.5M in Q3 2013. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

  • Aurora Investment Counsel reported no remaining Jazz Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Aurora Investment Counsel sold 2,175 Jazz Pharmaceuticals shares in Q3 2014, an estimated $320K.
  • Aurora Investment Counsel first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Aurora Investment Counsel's Jazz Pharmaceuticals position peaked at $2.5M in Q3 2013.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on Aurora Investment Counsel's 13F filing for Q3 2014, filed 29 Oct 2014.